drugset / Trial / NCT01046812

Halitosis Devised Questionnaire Evaluating a New Treatment

NCT01046812

Completed 30 enrolled New York Head & Neck Institute
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The investigators propose a novel assessment of oral malodor (halitosis) by a quality of life (QOL) questionnaire designed specifically for halitosis and a new treatment for halitosis by improvement of mouth dryness.

Timeline

Start
2009-09
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Caphosol Other / unclassified Oral

Indications

No indication recorded.